Vascular Calcification: A Passive Process That Requires Active Inhibition

Area of Science:

• Cardiovascular Science
• Biochemistry
• Pathology

Background:

• Cardiovascular diseases, driven by atherosclerosis and arterial stiffening, are leading causes of death.
• Pathological calcification of cardiovascular structures, including blood vessels (vascular calcification), is a common feature.
• Vascular calcification involves hydroxyapatite crystal accumulation, linked to aging and diseases like diabetes and chronic kidney disease.

Purpose of the Study:

• To summarize the understanding of vascular calcification mechanisms.
• To highlight the roles of passive and active processes in calcification.
• To outline current therapeutic strategies for preventing vascular calcification.

Main Methods:

• Review of existing evidence on vascular calcification.
• Analysis of the roles of hyperphosphatemia and pyrophosphate metabolism.
• Examination of current in vivo treatment approaches.

Main Results:

• Vascular calcification is characterized by hydroxyapatite deposition.
• Calcification involves both passive (physicochemical) and active (cellular) processes.
• Hyperphosphatemia promotes passive calcification, while impaired pyrophosphate metabolism drives active calcification.

Conclusions:

• Effective prevention of vascular calcification requires managing hyperphosphatemia and enhancing pyrophosphate availability.
• Therapeutic strategies include phosphate binders and methods to increase pyrophosphate.
• Understanding the interplay between passive and active processes is crucial for future treatments.